Wednesday, December 23, 2015

Buy Syngene

Company Background :

Syngene is one of the leading contract research organizations in the country offering a suite of integrated, end-to-end discovery and development services for novel molecular entities across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition companies. The company offers services through flexible business models that are customised to client’s requirements. These range from a full-time equivalent to a fee-for-service model, or a combination thereof.

Syngene delivers its services through a combination of scientific talent, globally accredited systems and R&D infrastructure. At the end of FY15, its tangible fixed assets (gross block) were Rs 931 cr. the company’s laboratory and manufacturing facilities located in Bengaluru are spread over more than 9 lakh sq. ft.  As of May 31, 2015, the company had 2,122 scientists, including 258 Ph.Ds. and 1,665 scientists with a Master’s degree.

Recommendation :

Investors with long time horizon of holding for more than 12 months should consider adding this scrip to their portfolio.  Buy on a weak days around Rs.350 levels and hold for a target of Rs.525

Smart Investor

No.24 Pattamal Plaza
3rd Cross Kammanahalli

Mobile / Whatsapp -08105-737-966